Cooperative nongenomic and genomic actions on thyroid hormone mediated-modulation of T cell proliferation involve up-regulation of thyroid hormone receptor and inducible nitric oxide synthase expression

Journal of Cellular Physiology

Volumn 226, Issue 12, 2011, Pages 3208-3218

  Barreiro Arcos, Maria L ^a   Sterle, Helena A ^a   Paulazo, Maria A ^a   Valli, Eduardo ^a,b   Klecha, Alicia J ^a,b   Isse, Blanca ^c   Pellizas, Claudia G ^d   Farias, Ricardo N ^c   Cremaschi, Graciela A ^a,b  

^a Centre de Estudios Farmacologicos y Botanicos   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^d UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE C ZETA; THYROID HORMONE; THYROID HORMONE RECEPTOR;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; GENOME; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; UPREGULATION;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; PROTEIN TRANSPORT; RNA, MESSENGER; SIGNAL TRANSDUCTION; SPHINGOMYELIN PHOSPHODIESTERASE; T-LYMPHOCYTES; THYROID HORMONE RECEPTORS ALPHA; THYROXINE; TIME FACTORS; TRIIODOTHYRONINE; UP-REGULATION;

EID: 79961199391     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22681     Document Type: Article

References (44)

1. Barish GD, Downes M, Alaynick WA, Yu RT, Ocampo CB, Bookout AL, Mangelsdorf DJ, Evans RM. 2005. A nuclear receptor atlas: Macrophage activation. Mol Endocrinol 19: 2466-2477.
2. Barreiro Arcos ML, Gorelik G, Klecha A, Cremaschi GA. 2003. Inducible nitric oxide synthase-mediated proliferation of a T lymphoma cell line. Nitric Oxide 8: 111-118.
3. Barreiro Arcos ML, Gorelik G, Klecha A, Genaro AM, Cremaschi GA. 2006. Thyroid hormones increase inducible nitric oxide synthase gene expression downstream from PKC-zeta in murine tumor T lymphocytes. Am J Physiol Cell Physiol 291: C327-C336.
4. Bassett JH, Harvey CB, Williams GR. 2003. Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions. Mol Cell Endocrinol 213: 1-11.
5. Bergh JJ, Lin HY, Lansing L, Mohamed SN, Davis FB, Mousa S, Davis PJ. 2005. Integrin αvβ3 contains a cell surface receptor for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology 146: 2864-2871.
6. Cheng SY, Leonard JL, Davis PJ. 2010. Molecular aspects of thyroid hormone actions. Endocr Rev 31: 139-170.
7. Cremaschi GA, Gorelik G, Klecha A, Lysionek A, Genaro AM. 2000. Chronic stress influences immune system through thyroid axis. Life Sci 67: 3171-3179.
8. D'Arezzo S, Incerpi S, Davis FB, Acconcia F, Marino M, Farias RN, Davis PJ. 2004. Rapid nongenomic effects of 3, 5, 3'-triiodo-L-thyronine on the intracellular pH of L-6 myoblasts are mediated by intracellular calcium mobilization and kinase pathways. Endocrinology 145: 5694-5703.
9. Davis FB, Mousa SA, O'Connor L, Mohamed S, Lin HY, Cao HJ, Davis PJ. 2004. Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface. Circ Res 94: 1500-1506.
10. Davis PJ, Leonard JL, Davis FB. 2008. Mechanisms of nongenomic actions of thyroid hormone. Front Neuroendocrinol 29: 211-218.
11. Davis PJ, Davis FB, Lin HY, Mousa SA, Zhou M, Luidens MK. 2009. Translational implications of nongenomic actions of thyroid hormone initiated at its integrin receptor. Am J Physiol Endocrinol Metab 297: E1238-E1246.
12. Farias RN, Fiore AM, Pedersen JZ, Incerpi S. 2006. Nongenomic actions of thyroid hormones: A focus on membrane transport systems. Curr Med Chem Immunol Endocr Metab Agents 6: 241-254.
13. Flamant F, Gauthier K, Samarut J. 2007. Thyroid hormones signaling is getting more complex: STORMs are coming. Mol Endocrinol 21: 321-333.
14. Foster M, Montecino-Rodriguez E, Clark R, Dorshkind K. 1998. Regulation of B and T cell development by anterior pituitary hormones. Cell Mol Life Sci 54: 1076-1082.
15. Frick LR, Rapanelli M, Bussmann UA, Klecha AJ, Arcos ML, Genaro A, Cremaschi GA. 2009. Involvement of thyroid hormones in the alterations of T-cell immunity and tumor progression induced by chronic stress. Biol Psychiatry 65: 935-942.
16. Gorelik G, Barreiro Arcos ML, Klecha AJ, Cremaschi GA. 2002. Differential expression of protein kinase C isoenzymes related to high nitric oxide synthase activity in a T lymphoma cell line. Biochim Biophys Acta 1588: 179-188.
17. Halvorson MJ, Coligan JE, Sturmhofel K. 1996. The vitronectin receptor (alphaV beta 3) as an example for the role of integrins in T lymphocyte stimulation. Immunol Res 15: 16-29.
18. Hirai T, Chida K. 2003. Protein kinase Czeta (PKCzeta): Activation mechanisms and cellular functions. J Biochem 133: 1-7.
19. Hiroi Y, Kim HH, Ying H, Furuya F, Huang Z, Simoncini T, Noma K, Ueki K, Nguyen NH, Scanlan TS, Moskowitz MA, Cheng SY, Liao JK. 2006. Rapid nongenomic actions of thyroid hormone. Proc Natl Acad Sci USA 103: 14104-14109.
20. Hodkinson CF, Simpson EE, Beattie JH, O'Connor JM, Campbell DJ, Strain JJ, Wallace JM. 2009. Preliminary evidence of immune function modulation by thyroid hormones in healthy men and women aged 55-70 years. J Endocrinol 202: 55-63.
21. Jirmanova L, Ashwell JD. 2010. T cell priming: Let there be light. Cell Res 20: 608-610.
22. Klecha AJ, Genaro AM, Lysionek AE, Caro RA, Coluccia AG, Cremaschi GA. 2000. Experimental evidence pointing to the bidirectional interaction between the immune system and the thyroid axis. Int J Immunopharmacol 22: 491-500.
23. Klecha AJ, Genaro AM, Gorelik G, Barreiro Arcos ML, Silberman DM, Schuman M, Garcia SI, Pirola C, Cremaschi GA. 2006. Integrative study of hypothalamus-pituitary-thyroid-immune system interaction: Thyroid hormone-mediated modulation of lymphocyte activity through the protein kinase C signaling pathway. J Endocrinol 189: 45-55.
24. Lin HY, Martino LJ, Wilcox BD, Davis FB, Gordinier JK, Davis PJ. 1998. Potentiation by thyroid hormone of human IFN-gamma-induced HLA-DR expression. J Immunol 161: 843-849.
25. Lin HY, Sun M, Tang HY, Lin C, Luidens MK, Mousa SA, Incerpi S, Drusano GL, Davis FB, Davis PJ. 2009. L-Thyroxine vs. 3, 5, 3'-triiodo-L-thyronine and cell proliferation: Activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase. Am J Physiol Cell Physiol 296: C980-C991.
26. Mascanfroni I, Montesinos Mdel M, Susperreguy S, Cervi L, Ilarregui JM, Ramseyer VD, Masini-Repiso AM, Targovnik HM, Rabinovich GA, Pellizas CG. 2008. Control of dendritic cell maturation and function by triiodothyronine. FASEB J 22: 1032-1042.
27. Mascanfroni ID, Montesinos MD, Alamino VA, Susperreguy S, Nicola JP, Ilarregui JM, Masini-Repiso AM, Rabinovich GA, Pellizas CG. 2010. Nuclear factor (NF)-{kappa}B-dependent thyroid hormone receptor {beta}1-expression controls dendritic cell function via AKT signaling. J Biol Chem 285: 9569-9582.
28. Mezosi E, Szabo J, Nagy EV, Borbely A, Varga E, Paragh G, Varga Z. 2005. Nongenomic effect of thyroid hormone on free-radical production in human polymorphonuclear leukocytes. J Endocrinol 185: 121-129.
29. Moeller LC, Cao X, Dumitrescu AM, Seo H, Refetoff S. 2006. Thyroid hormone mediated changes in gene expression can be initiated by cytosolic action of the thyroid hormone receptor beta through the phosphatidylinositol 3-kinase pathway. Nucl Recept Signal 4: e020.
30. Moscat J, Rennert P, Diaz-Meco MT. 2006. PKCzeta at the crossroad of NF-kappaB and Jak1/Stat6 signaling pathways. Cell Death Differ 13: 702-711.
31. Mousa SS, Davis FB, Davis PJ, Mousa SA. 2010. Human platelet aggregation and degranulation is induced in vitro by L-thyroxine, but not by 3, 5, 3'-triiodo-l-thyronine or diiodothyropropionic acid (DITPA). Clin Appl Thromb Hemost 16: 288-293.
32. Müller G, Ayoub M, Storz P, Rennecke J, Fabbro D, Pfizenmaier K. 1995. PKC zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by ceramide and arachidonic acid. EMBO J 14: 1961-1969.
33. Sánchez-Valdepeñas C, Punzón C, San-Antonio B, Martin AG, Fresno M. 2007. Differential regulation of p65 and c-Rel NF-kappaB transactivating activity by Cot, protein kinase C zeta and NIK protein kinases in CD3/CD28 activated T cells. Cell Signal 19: 528-537.
34. Scapin S, Leoni S, Spagnuolo S, Fiore AM, Incerpi S. 2009. Short-term effects of thyroid hormones on Na+-K+-ATPase activity of chick embryo hepatocytes during development: Focus on signal transduction. Am J Physiol Cell Physiol 296: C4-C12.
35. Seminario MC, Wange RL. 2003. Lipid phosphatases in the regulation of T cell activation: Living up to their PTEN-tial. Immunol Rev 192: 80-97.
36. Shih A, Zhang S, Cao HJ, Tang HY, Davis FB, Davis PJ, Lin HY. 2004. Disparate effects of thyroid hormone on actions of epidermal growth factor and transforming growth factor-alpha are mediated by 3', 5'-cyclic adenosine 5'-monophosphate-dependent protein kinase II. Endocrinology 145: 1708-1717.
37. Silberman DM, Zorrilla-Zubilete M, Cremaschi GA, Genaro AM. 2005. Protein kinase C-dependent NF-kappaB activation is altered in T cells by chronic stress. Cell Mol Life Sci 62: 1744-1754.
38. Simarro M, Calvo J, Vilà JM, Places L, Padilla O, Alberola-Ila J, Vives J, Lozano F. 1999. Signaling through CD5 involves acidic sphingomyelinase, protein kinase C-zeta, mitogen-activated protein kinase kinase, and c-Jun NH2-terminal kinase. J Immunol 162: 5149-5155.
39. Stagi S, Azzari C, Bindi G, Galluzzi F, Nanni S, Salti R, Vierucci A. 2005. Undetectable serum IgA and low IgM concentration in children with congenital hypothyroidism. Clin Immunol 116: 94-98.
40. Storey NM, Gentile S, Ullah H, Russo A, Muessel M, Erxleben C, Armstrong DL. 2006. Rapid signaling at the plasma membrane by a nuclear receptor for thyroid hormone. Proc Natl Acad Sci USA 103: 5197-5201.
41. Toell A, Kröncke KD, Kleinert H, Carlberg C. 2002. Orphan nuclear receptor binding site in the human inducible nitric oxide synthase promoter mediates responsiveness to steroid and xenobiotic ligands. J Cell Biochem 85: 72-82.
42. Vallortigara J, Chassande O, Higueret P, Enderlin V. 2008. Thyroid hormone receptor alpha plays an essential role in the normalization of adult-onset hypothyroidism-related hypoexpression of synaptic plasticity target genes in striatum. J Neuroendocrinol 21: 49-56.
43. Vinodhkumar R, Song YS, Devaki T. 2008. Romidepsin (depsipeptide) induced cell cycle arrest, apoptosis and histone hyperacetylation in lung carcinoma cells (A549) are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expression. Biomed Pharmacother 62: 85-93.
44. Yen PM, Ando S, Feng X, Liu Y, Maruvada P, Xia X. 2006. Thyroid hormone action at the cellular, genomic and target gene levels. Mol Cell Endocrinol 246: 121-127.